NCT03778749

Brief Summary

In intensive care unit (ICU) patients who are mechanically ventilated for a longer period of time, there might be a difference in accuracy and performance of neuromuscular transmission monitoring \[as measured by the train-of-four (TOF)%\] due to a pre-existing TOF fade, correlated to some form of acquired muscle weakness. The investigators therefore propose to search for and compare the optimal monitoring techniques (acceleromyography vs. electromyography) and the optimal muscle monitoring site (peripheral-adductor pollicis vs. central-corrugator supercilii) in ICU patients who require prolonged mechanical ventilation.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2019

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 12, 2018

Completed
7 days until next milestone

First Posted

Study publicly available on registry

December 19, 2018

Completed
1 month until next milestone

Study Start

First participant enrolled

January 25, 2019

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 16, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 16, 2019

Completed
Last Updated

May 21, 2019

Status Verified

May 1, 2019

Enrollment Period

4 months

First QC Date

December 12, 2018

Last Update Submit

May 17, 2019

Conditions

Keywords

train-of-four monitoringacceleromyographyelectromyographyintensive care unit

Outcome Measures

Primary Outcomes (1)

  • pre-existing neuromuscular fade (TOF% <90), correlated to some form of ICU acquired muscle weakness, in ICU patients mechanically ventilated for more than 72 hrs.

    to find whether any patients show any pre-existing neuromuscular fade or develop such weakness over the 72 hours of study period in ICU

    72 hours of study period in ICU

Secondary Outcomes (1)

  • fade (TOF% <90) difference between central (corrugator supercilii) and peripheral (adductor pollicis) muscles in ICU patients who require prolonged mechanical ventilation.

    72 hours of study period in ICU

Other Outcomes (1)

  • optimal monitor for use in the ICU setting

    72 hours of study period in ICU

Study Arms (3)

electromyographic NMT monitoring at the hand

EXPERIMENTAL

In 20 mechanically ventilated ICU patients, TOF measurements will be performed every 24 hrs, once a day, at the same time, over the 72 hrs the study will take place in the ICU.

Diagnostic Test: TOF measurements

acceleromyographic NMT monitoring at the hand

EXPERIMENTAL

In 20 mechanically ventilated ICU patients, TOF measurements will be performed every 24 hrs, once a day, at the same time, over the 72 hrs the study will take place in the ICU.

Diagnostic Test: TOF measurements

acceleromyographic NMT monitoring at the eyebrow

EXPERIMENTAL

In 20 mechanically ventilated ICU patients, TOF measurements will be performed every 24 hrs, once a day, at the same time, over the 72 hrs the study will take place in the ICU.

Diagnostic Test: TOF measurements

Interventions

TOF measurementsDIAGNOSTIC_TEST

The investigators will determine how the TOF% values vary in each individual patient, over time, in ICU.

acceleromyographic NMT monitoring at the eyebrowacceleromyographic NMT monitoring at the handelectromyographic NMT monitoring at the hand

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • yr. old or older
  • expected to require mechanical ventilation for more than 72 hrs

You may not qualify if:

  • degenerative neurological disease
  • receive drugs interfering with NMT (e.g., aminoglycosides or magnesium)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

OLV Hospital

Aalst, 9300, Belgium

Location

Related Publications (2)

  • Naguib M, Brull SJ, Johnson KB. Conceptual and technical insights into the basis of neuromuscular monitoring. Anaesthesia. 2017 Jan;72 Suppl 1:16-37. doi: 10.1111/anae.13738.

    PMID: 28044330BACKGROUND
  • Cammu G, Neyens E, Coddens J, Van Praet F, De Decker K. Postoperative residual curarisation is still an issue when weaning patients in intensive care following cardiac surgery. Anaesth Intensive Care. 2018 Nov;46(6):634-636. No abstract available.

    PMID: 30447682BACKGROUND

Study Officials

  • Guy Cammu, MD,PhD

    Onze-Lieve-Vrouw Ziekenhuis, Aalst, Belgium

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Model Details: Twenty mechanically ventilated ICU patients: the investigators will compare the mean TOF% between three different measurement techniques in 20 mechanically ventilated ICU patients: 1/electromyographic neuromuscular transmission monitoring at the hand muscle - 2/acceleromyographic neuromuscular transmission monitoring at the hand muscle - 3/acceleromyographic neuromuscular transmission monitoring at the eyebrow muscle; and the investigators will determine how the three TOF% values vary in each individual patient.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

December 12, 2018

First Posted

December 19, 2018

Study Start

January 25, 2019

Primary Completion

May 16, 2019

Study Completion

May 16, 2019

Last Updated

May 21, 2019

Record last verified: 2019-05

Locations